PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM ACHIEVES FIRST REVENUE, page-12

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    That only applies to intial IND. Now that the clock is stopped, its stopped. No timeframes. FDA could ask questions months from now so no questions may not be a good thing - just potentially extends the wait. IMO
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.